Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:13:31.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding the details of a Phase 1/2 study for metastatic melanoma, including specific inclusion and exclusion criteria, as well as the study's goals and design. The only notable addition is the mention of 'Metastatic Melanoma' and a new revision number.
    Difference
    31%
    Check dated 2025-04-16T13:06:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T06:51:22.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:26:25.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:37:05.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:00:11.000Z thumbnail image

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.